H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Raises Target Price to $31
Dynavax Is Maintained at Buy by HC Wainwright & Co.
Dynavax Technologies Analyst Ratings
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies: Strong Buy Rating Backed by HEPLISAV-B Growth and Strategic Initiatives
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax's Market Dominance and Buoyant Growth Prospects Affirm Buy Rating
Dynavax's Strong Growth and Market Share Expansion Drive Buy Rating
Dynavax Technologies Analyst Ratings
Dynavax Technologies Analyst Ratings